The Biomedical Advanced Research & Development Authority (BARDA) funds the development of medical countermeasures to address public health preparedness and consequences of chemical, biological, radiological, and nuclear (CBRN) incidents, pandemic influenza, and emerging infectious diseases.
This includes funding for vaccines, therapeutics, diagnostics, medical devices, and supply chain resiliency.
These opportunities are typically available through Broad Agency Announcements (BAAs) and Requests for Proposals (RFPs) directly from BARDA or through industry consortiums including the Rapid Response Partnership Vehicle (RRPV) Consortium and the Biopharmaceutical Manufacturing Preparedness (BioMaP) Consortium.
BARDA Consulting can help your organization navigate the BARDA funding landscape and put your potential project in the best position for a successful award.